Literature DB >> 22913313

Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit.

Greta L Piper1, Lewis J Kaplan.   

Abstract

BACKGROUND: Multi-drug-resistant organisms (MDRO) complicate care increasingly on the general ward and in the emergency department, operating room, and intensive care unit (ICU). Whereas barrier precautions are important in limiting transmission of MDRO between patients, few tactics have been defined that reduce the genesis of MDRO.
METHOD: Review of pertinent English-language literature.
RESULTS: Antibiotic heterogeneity practices, as part of an overall antimicrobial drug stewardship program, offer one readily deployable means to reduce selection pressure for MDRO development in the ICU. The data underpinning this approach and data derived from its use indicate that, especially in surgical ICUs, heterogeneity of antibiotic prescribing can preserve or restore microbial ecology, reduce the prevalence of MDRO and the incidence of infections caused thereby, and facilitate the implementation and effectiveness of other antibiotic-sparing tactics, such as de-escalation.
CONCLUSION: Heterogeneity of antibiotic prescribing is effective in preventing the dissemination of MDRO pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913313     DOI: 10.1089/sur.2012.121

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  6 in total

Review 1.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

Review 2.  Methodology in improving antibiotic implementation policies.

Authors:  Onur Özgenç
Journal:  World J Methodol       Date:  2016-06-26

3.  Impact of Multi-Drug-Resistant Pneumonia on Outcomes of Critically Ill Trauma Patients.

Authors:  Ishita Rai; Andrew H Stephen; Qing Lu; Daithi S Heffernan
Journal:  Surg Infect (Larchmt)       Date:  2020-01-02       Impact factor: 2.150

4.  Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London.

Authors:  Luke S P Moore; Rachel Freeman; Mark J Gilchrist; Myriam Gharbi; Eimear T Brannigan; Hugo Donaldson; David M Livermore; Alison H Holmes
Journal:  J Antimicrob Chemother       Date:  2014-08-12       Impact factor: 5.790

5.  Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study.

Authors:  Tetsuya Matsumoto; Akira Yuasa; Ryan Miller; Clive Pritchard; Takahisa Ohashi; Amer Taie; Jason Gordon
Journal:  Pharmacoecon Open       Date:  2022-09-15

Review 6.  Strategies to minimize antibiotic resistance.

Authors:  Chang-Ro Lee; Ill Hwan Cho; Byeong Chul Jeong; Sang Hee Lee
Journal:  Int J Environ Res Public Health       Date:  2013-09-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.